FineMark National Bank & Trust’s Precigen PGEN Stock Holding History

FineMark National Bank & Trust’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-428	Closed	-$11K	–	822
2016 Q4	$11K	Hold	428	–	–	﹤0.01%	937
2016 Q3	$12K	Hold	428	–	–	﹤0.01%	909
2016 Q2	$11K	Buy	428 +256	+149%	+$7.26K	﹤0.01%	933
2016 Q1	$6K	Buy	172 +98	+132%	+$3.08K	﹤0.01%	1011
2015 Q4	$2K	Buy	+74	New	+$2.49K	﹤0.01%	1193
2014 Q4	–	Sell	-523	Closed	-$9K	–	1437
2014 Q3	$9K	Hold	523	–	–	﹤0.01%	1040
2014 Q2	$13K	Hold	523	–	–	﹤0.01%	982
2014 Q1	$13K	Buy	+523	New	+$14.5K	﹤0.01%	994

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

FineMark National Bank & Trust's PGEN Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Precigen (PGEN) in Q1 2017, closing a stake of 428 shares — an estimated $11K sold.

FineMark National Bank & Trust first reported a position in PGEN in Q1 2014 and held it in 8 quarters. The position peaked at $13K in Q2 2014. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

FineMark National Bank & Trust reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 428 Precigen shares in Q1 2017, an estimated $11K.
FineMark National Bank & Trust first reported a position in Precigen in Q1 2014 and held it in 8 quarters.
FineMark National Bank & Trust's Precigen position peaked at $13K in Q2 2014.
154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.